These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fukugiside, a biflavonoid from Garcinia travancorica inhibits biofilm formation of Streptococcus pyogenes and its associated virulence factors. Nandu TG; Subramenium GA; Shiburaj S; Viszwapriya D; Iyer PM; Balamurugan K; Rameshkumar KB; Karutha Pandian S J Med Microbiol; 2018 Sep; 67(9):1391-1401. PubMed ID: 30052177 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999. Critchley IA; Sahm DF; Thornsberry C; Blosser-Middleton RS; Jones ME; Karlowsky JA Diagn Microbiol Infect Dis; 2002 Feb; 42(2):129-35. PubMed ID: 11858909 [TBL] [Abstract][Full Text] [Related]
5. Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes. Balaji K; Thenmozhi R; Pandian SK Indian J Med Res; 2013 May; 137(5):963-71. PubMed ID: 23760384 [TBL] [Abstract][Full Text] [Related]
6. Essential oils from Origanum vulgare and Salvia officinalis exhibit antibacterial and anti-biofilm activities against Streptococcus pyogenes. Wijesundara NM; Rupasinghe HPV Microb Pathog; 2018 Apr; 117():118-127. PubMed ID: 29452197 [TBL] [Abstract][Full Text] [Related]
7. Biofilm formation or internalization into epithelial cells enable Streptococcus pyogenes to evade antibiotic eradication in patients with pharyngitis. Ogawa T; Terao Y; Okuni H; Ninomiya K; Sakata H; Ikebe K; Maeda Y; Kawabata S Microb Pathog; 2011; 51(1-2):58-68. PubMed ID: 21443942 [TBL] [Abstract][Full Text] [Related]
9. Application of Medicinal Plants as a Source for Therapeutic Agents Against Streptococcus pyogenes Infections. Adil M; Khan R; Rupasinghe HPV Curr Drug Metab; 2018; 19(8):695-703. PubMed ID: 29595103 [TBL] [Abstract][Full Text] [Related]
10. [Therapy of skin and soft tissue infections from dermatologist's point of view]. Sunderkötter C Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S93-4. PubMed ID: 25429541 [No Abstract] [Full Text] [Related]
11. Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. Baldassarri L; Creti R; Recchia S; Imperi M; Facinelli B; Giovanetti E; Pataracchia M; Alfarone G; Orefici G J Clin Microbiol; 2006 Aug; 44(8):2721-7. PubMed ID: 16891483 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus. Afset JE; Maeland JA Scand J Infect Dis; 2003; 35(2):84-9. PubMed ID: 12693555 [TBL] [Abstract][Full Text] [Related]
13. Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis. Gonzalez Moreno M; Trampuz A; Di Luca M J Antimicrob Chemother; 2017 Nov; 72(11):3085-3092. PubMed ID: 28961884 [TBL] [Abstract][Full Text] [Related]
14. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Gilmer DB; Schmitz JE; Euler CW; Fischetti VA Antimicrob Agents Chemother; 2013 Jun; 57(6):2743-50. PubMed ID: 23571534 [TBL] [Abstract][Full Text] [Related]
15. Manuka honey inhibits the development of Streptococcus pyogenes biofilms and causes reduced expression of two fibronectin binding proteins. Maddocks SE; Lopez MS; Rowlands RS; Cooper RA Microbiology (Reading); 2012 Mar; 158(Pt 3):781-790. PubMed ID: 22294681 [TBL] [Abstract][Full Text] [Related]
16. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan. Watanabe S; Ohnishi T; Yuasa A; Kiyota H; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Manabe M; Suzuki T; Otsuka F; Aihara M; Iozumi K; Tamaki T; Funada Y; Shinozaki M; Kobayashi M; Okuda M; Kikyo G; Kikuchi K; Okada Y; Takeshima M; Kaneko O; Ogawa N; Ito R; Okuyama R; Shimada S; Shimizu T; Hatta N; Manabu M; Tsutsui K; Tanaka T; Miyachi Y; Asada H; Furukawa F; Kurokawa I; Iwatsuki K; Hide M; Muto M; Yamamoto O; Niihara H; Takagaki K; Kubota Y; Sayama K; Sano S; Furue M; Kanekura T J Infect Chemother; 2017 Aug; 23(8):503-511. PubMed ID: 28645883 [TBL] [Abstract][Full Text] [Related]
17. Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Cho KH; Caparon MG Mol Microbiol; 2005 Sep; 57(6):1545-56. PubMed ID: 16135223 [TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan. Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753 [TBL] [Abstract][Full Text] [Related]
19. The Second Messenger c-di-AMP Regulates Diverse Cellular Pathways Involved in Stress Response, Biofilm Formation, Cell Wall Homeostasis, SpeB Expression, and Virulence in Streptococcus pyogenes. Fahmi T; Faozia S; Port GC; Cho KH Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936159 [TBL] [Abstract][Full Text] [Related]